NuntioBot @NuntioBot

Not investment advice. Tweets delayed. NuntioBot.com Joined December 2022

Tweets

16K
Followers

9K
Following

59
Likes

29

NuntioBot @NuntioBot

9 hours ago

$HSDT 08:10 on Sep. 29 2025 Preeminent SOL Treasury Company Helius (NASDAQ:HSDT) Announces Corporate Name Change to Solana Company and Letter of Intent with Solana Foundation

0 0 0 1K 0

NuntioBot @NuntioBot

9 hours ago

$SYNX 08:05 on Sep. 29 2025 Silynxcom Lands $100,000 Order from Leading Military Unit for Advanced Tactical Communication Headsets

0 0 0 1K 0

NuntioBot @NuntioBot

9 hours ago

$UCAR 08:00 on Sep. 29 2025 U Power Partners with IoTeX to Launch Tokenized Real-World Assets, Pioneering AI-Powered Web3 EV Battery Swapping Infrastructure

0 0 1 1K 0

NuntioBot @NuntioBot

9 hours ago

$LSTA 08:00 on Sep. 29 2025 Lisata Therapeutics Announces Encouraging Preliminary Results from the Pancreatic Cancer Cohort of the CENDIFOX Trial

0 0 0 1K 0

$COSM 08:00 on Sep. 29 2025 Cosmos Health CEO Issues Letter to Shareholders: Building a Global Healthcare Powerhouse with $300M Digital Financing Facility, U.S. Manufacturing Expansion, and AI Innovation

0 0 1 1K 0

NuntioBot @NuntioBot

9 hours ago

$EA PR during News Halt on Sep. 29 2025 EA Announces Agreement to be Acquired by PIF, Silver Lake, and Affinity Partners for $55 Billion

0 0 0 982 0

NuntioBot @NuntioBot

9 hours ago

$KIDZ 08:00 on Sep. 29 2025 Classover and Litespace Announce Strategic Partnership with the Goal of Transforming AI Hiring in Education

0 0 0 976 0

NuntioBot @NuntioBot

9 hours ago

$NVFY 08:00 on Sep. 29 2025 Nova Lifestyle Inc. Announces A US$5.66 Million Investment in a Fund to Hold Interest in SpaceX Shares

0 0 1 970 0

NuntioBot @NuntioBot

9 hours ago

$KALA PR during News Halt on Sep. 29 2025 KALA BIO Announces Topline Results from CHASE Phase 2b Clinical Trial Evaluating KPI-012 for the Treatment of Persistent Corneal Epithelial Defect (PCED) Did Not Meet Primary Endpoint

0 0 0 1K 0

NuntioBot @NuntioBot

10 hours ago

$MDCX 07:30 on Sep. 29 2025 Medicus Pharma Ltd. Receives Positive Feedback From the Food and Drug Adminstration (FDA) Type C Meeting Supporting the Development of Skinject

0 1 1 1K 0

NuntioBot @NuntioBot

10 hours ago

$DWTX 07:15 on Sep. 29 2025 Dogwood Therapeutics Secures Exclusive Worldwide, Royalty Free License to Develop and Commercialize SP16 as a Treatment for Cancer Related Pain in an All-Stock Transaction Underscoring the Company's Dedication to Improving the Lives of Cancer Patients

0 0 0 1K 0

NuntioBot @NuntioBot

10 hours ago

$STSS 07:00 on Sep. 29 2025 Crypto.com and Sharps Technology Partner to Strengthen Solana Ecosystem Growth Through Institutional Treasury Solutions

0 0 1 1K 0

NuntioBot @NuntioBot

10 hours ago

$APLT 07:00 on Sep. 29 2025 Applied Therapeutics Provides Update Following Meeting with FDA

0 0 0 1K 0

NuntioBot @NuntioBot

10 hours ago

$RDHL 07:00 on Sep. 29 2025 RedHill Wins New York Supreme Court Appeal, Upholding $10 Million Summary Judgment Against Kukbo

0 0 2 1K 0

NuntioBot @NuntioBot

11 hours ago

$ENTA 06:30 on Sep. 29 2025 Enanta Pharmaceuticals Reports Positive Topline Results from its Phase 2b Study of Zelicapavir for the Treatment of Respiratory Syncytial Virus (RSV) in High-Risk Adults

0 0 0 2K 0

NuntioBot @NuntioBot

11 hours ago

$DVLT 06:01 on Sep. 29 2025 IBM Commits to Invest 20,000 Hours, an Expected Investment Value of $5,000,000, of Solution Architects and AI Engineers to Advance Datavault AI's Partnership

0 0 1 2K 0

NuntioBot @NuntioBot

12 hours ago

$WIMI 05:00 on Sep. 29 2025 WIMI Hologram Cloud (NASDAQ: WIMI) Reports 926% Net Income Growth for First Half of 2025

0 1 6 2K 0

NuntioBot @NuntioBot

3 days ago

$SOS 16:10 on Sep. 26 2025 SOS Limited Reports 2025 Semi-Annual Financial Results

0 0 3 2K 0

NuntioBot @NuntioBot

3 days ago

$ENTA 16:01 on Sep. 26 2025 Enanta Pharmaceuticals to Present Topline Results from its Phase 2b Study Evaluating Zelicapavir for the Treatment of Respiratory Syncytial Virus (RSV) in High-Risk Adults